RecruitingPhase 2NCT07368972

Study of DISC-0974-201 in Participants With IBD and Anemia

RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation

Sponsor

Disc Medicine, Inc

Enrollment

21 participants

Start Date

Feb 20, 2026

Study Type

INTERVENTIONAL

Conditions

Anemia Inflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (IBD); Anemia

Summary

This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called DISC-0974 and a drug called Placebo for people with anemia, inflammatory bowel disease (ibd), and other related conditions. The study is currently recruiting participants at 9 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDISC-0974

DISC-0974 is administered subcutaneously.

DRUGPlacebo

Placebo is administered subcutaneously

Locations(13)

One of a Kind Clinical Research Center, LLC

Scottsdale, Arizona, United States

Dolphin Medical Research

Doral, Florida, United States

Clinical Research of Osceola, LLC

Kissimmee, Florida, United States

Anchor Medical Research, LLC

Miami, Florida, United States

Gastro Health - Galloway Care Center

Miami, Florida, United States

Ezy Medical Research, Co

Miami Lakes, Florida, United States

Guardian Angel Research, Inc

Tampa, Florida, United States

KAD Clinical Research

St Louis, Missouri, United States

Gastro Health - Cincinnati

Cincinnati, Ohio, United States

Gastro Health - Blue Ash Care Center

Cincinnati, Ohio, United States

University Gastroenterology Clinical Research Department

Providence, Rhode Island, United States

One of a Kind Clinical Research Center, LLC

Kingwood, Texas, United States

Siena Research Network

Sugar Land, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07368972

Related Trials

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT07422480156 locations

A Study of Luspatercept in People With Anemia

NCT077254977 locations

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT0532019828 locations

Screening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolescents With Increased Cardiovascular Risk Due to Chronic Diseases Such as Congenital Heart Disease, Chronic Inflammatory Bowel Disease, Celiac Disease and Rheumatic Disorders

NCT077164881 location

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

NCT072241131 location